Cloverfields Capital Group LP bought a new position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,191 shares of the medical research company’s stock, valued at approximately $5,409,000. Thermo Fisher Scientific makes up […]